Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3.
about
Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channelsDecreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss.Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.Antibodies to receptor activator of nuclear factor-κ B ligand (RANKL)
P2860
Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@en
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@nl
type
label
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@en
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@nl
prefLabel
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@en
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@nl
P2860
P1476
Osteoprotegerin to soluble rec ...... orosis who receive vitamin D3.
@en
P2093
Evangelos Terpos
P2860
P304
P356
10.1111/J.1600-0609.2004.00395.X
P577
2005-04-01T00:00:00Z